Research Article

Thyroid cancer incidence and clinicopathological distribution in bariatric surgery cases

Volume: 7 Number: 2 August 30, 2023
EN TR

Thyroid cancer incidence and clinicopathological distribution in bariatric surgery cases

Abstract

Aim: Obesity is strongly associated with increased risk of many cancer types. It is estimated that approximately 20% of all cancers are caused by overweight. It is considered that there is a direct relation between overweight and thyroid cancer. The aim of this study is to evaluate the incidence and clinicopathological distribution of thyroid cancer in bariatric surgery cases. Materials and Methods: The present study was conducted with a total of 2316 patients who underwent bariatric surgery because of morbid obesity in our metabolic and bariatric surgery clinic between April 2014 and November 2021. Results: It was found that the prevalence of thyroid cancer was 1.2% in morbidly obese cases. A total of 23 patients had papillary thyroid cancer (0.99%), 3 patients had follicular cancer (0.12%), 1 patient had medullary cancer (0.04%), and 1 patient had anaplastic cancer (0.04%). Conclusion: It was found in the present study that the most common cancer type was thyroid papillary cancer, and follicular, medullary, and anaplastic cancer were found to be less frequently. There appears to be a relation between Body Mass Index and the thyroid cancer risk.

Keywords

Project Number

yoktur

References

  1. 1. Amer A, Franchi L, Kanneganti TD, et al. Regulation of Legionella phagosome maturation and infection through flagellin and host Ipaf. J Biol Chem. 2006; 17;281(46):35217-23. doi: 10.1074/jbc.M604933200.
  2. 2. Iyengar NM, Hudis CA, Dannenberg AJ. Obesity and cancer: local and systemic mechanisms. Annu Rev Med. 2015; 66:297-309. doi: 10.1146/annurev-med-050913-022228. PMID: 25587653.
  3. 3. Filetti S, Durante C, Hartl D, et al. Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†. Ann Oncol. 2019; 1;30(12):1856-1883. doi: 10.1093/annonc/mdz400. PMID: 31549998.
  4. 4. Kitahara CM, Sosa JA. The changing incidence of thyroid cancer. Nat Rev Endocrinol. 2016; 12(11):646-653. doi: 10.1038/nrendo.2016.110. Epub 2016 Jul 15. PMID: 27418023.
  5. 5. Roman BR, Morris LG, Davies L. The thyroid cancer epidemic, 2017 perspective. Curr Opin Endocrinol Diabetes Obes. 2017; 24(5):332-336. doi: 10.1097/MED.0000000000000359. PMID: 28692457; PMCID: PMC5864110.
  6. 6. Sharen G, Zhang B, Zhao R, et al. Retrospective epidemiological study of thyroid nodules by ultrasound in asymptomatic subjects. Chin Med J (Engl). 2014;127(9):1661-5. PMID: 24791871.
  7. 7. Ali A, Mirza Y, Faizan U, et al. Association of Obesity and Thyroid Cancer at a Tertiary Care Hospital in Pakistan. Cureus. 2018; 26;10(3):e2364. doi: 10.7759/cureus.2364. PMID: 29805933; PMCID: PMC5969796.
  8. 8. Brito H, Santos AC, Preto J. et al. Obesity and Cancer: the Profile of a Population who Underwent Bariatric Surgery. OBES SURG. 2021; 31, 4682–4691 https://doi.org/10.1007/s11695-021-05626-0.

Details

Primary Language

English

Subjects

Clinical Sciences (Other)

Journal Section

Research Article

Early Pub Date

September 3, 2023

Publication Date

August 30, 2023

Submission Date

June 10, 2023

Acceptance Date

July 7, 2023

Published in Issue

Year 2023 Volume: 7 Number: 2

APA
Aksoy, E., Ergenç, Z., Ergenç, H., & Karaca Ocak, Ö. (2023). Thyroid cancer incidence and clinicopathological distribution in bariatric surgery cases. Journal of Biotechnology and Strategic Health Research, 7(2), 121-126. https://doi.org/10.34084/bshr.1312716
AMA
1.Aksoy E, Ergenç Z, Ergenç H, Karaca Ocak Ö. Thyroid cancer incidence and clinicopathological distribution in bariatric surgery cases. J Biotechnol and Strategic Health Res. 2023;7(2):121-126. doi:10.34084/bshr.1312716
Chicago
Aksoy, Erkan, Zeynep Ergenç, Hasan Ergenç, and Özlem Karaca Ocak. 2023. “Thyroid Cancer Incidence and Clinicopathological Distribution in Bariatric Surgery Cases”. Journal of Biotechnology and Strategic Health Research 7 (2): 121-26. https://doi.org/10.34084/bshr.1312716.
EndNote
Aksoy E, Ergenç Z, Ergenç H, Karaca Ocak Ö (August 1, 2023) Thyroid cancer incidence and clinicopathological distribution in bariatric surgery cases. Journal of Biotechnology and Strategic Health Research 7 2 121–126.
IEEE
[1]E. Aksoy, Z. Ergenç, H. Ergenç, and Ö. Karaca Ocak, “Thyroid cancer incidence and clinicopathological distribution in bariatric surgery cases”, J Biotechnol and Strategic Health Res, vol. 7, no. 2, pp. 121–126, Aug. 2023, doi: 10.34084/bshr.1312716.
ISNAD
Aksoy, Erkan - Ergenç, Zeynep - Ergenç, Hasan - Karaca Ocak, Özlem. “Thyroid Cancer Incidence and Clinicopathological Distribution in Bariatric Surgery Cases”. Journal of Biotechnology and Strategic Health Research 7/2 (August 1, 2023): 121-126. https://doi.org/10.34084/bshr.1312716.
JAMA
1.Aksoy E, Ergenç Z, Ergenç H, Karaca Ocak Ö. Thyroid cancer incidence and clinicopathological distribution in bariatric surgery cases. J Biotechnol and Strategic Health Res. 2023;7:121–126.
MLA
Aksoy, Erkan, et al. “Thyroid Cancer Incidence and Clinicopathological Distribution in Bariatric Surgery Cases”. Journal of Biotechnology and Strategic Health Research, vol. 7, no. 2, Aug. 2023, pp. 121-6, doi:10.34084/bshr.1312716.
Vancouver
1.Erkan Aksoy, Zeynep Ergenç, Hasan Ergenç, Özlem Karaca Ocak. Thyroid cancer incidence and clinicopathological distribution in bariatric surgery cases. J Biotechnol and Strategic Health Res. 2023 Aug. 1;7(2):121-6. doi:10.34084/bshr.1312716

Journal of Biotechnology and Strategic Health Research